|
|
Volumn 94, Issue , 1998, Pages 195-207
|
|
Tamoxifen and the endometrium.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1-(4-HYDROXYPHENYL)-1,2-DIPHENYL-1-BUTENE;
4 (1,2 DIPHENYL 1 BUTEN 1 YL)PHENOL;
ALKENE;
ANTIESTROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN;
ESTROGEN RECEPTOR;
PHENOL DERIVATIVE;
TAMOXIFEN;
ANIMAL;
BREAST TUMOR;
CANCER TRANSPLANTATION;
CARCINOMA;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG EFFECT;
ENDOMETRIUM;
ENDOMETRIUM TUMOR;
FEMALE;
GENETICS;
HUMAN;
HYPERPLASIA;
LEIOMYOSARCOMA;
MASS SCREENING;
MENOPAUSE;
METHODOLOGY;
MOUSE;
NEOPLASM;
NUDE MOUSE;
ONCOGENE RAS;
PATHOLOGY;
POLYP;
REVIEW;
RISK;
SECOND CANCER;
ALKENES;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CARCINOMA;
CLINICAL TRIALS;
ENDOMETRIAL NEOPLASMS;
ENDOMETRIUM;
ESTROGEN ANTAGONISTS;
ESTROGENS;
FEMALE;
GENES, RAS;
HUMANS;
HYPERPLASIA;
LEIOMYOSARCOMA;
MASS SCREENING;
MENOPAUSE;
MICE;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
NEOPLASMS, HORMONE-DEPENDENT;
NEOPLASMS, SECOND PRIMARY;
PHENOLS;
POLYPS;
RECEPTORS, ESTROGEN;
RISK;
TAMOXIFEN;
MLCS;
MLOWN;
|
|
EID: 0031619604
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-6189-7_11 Document Type: Review |
|
Times cited : (23)
|
|
References (34)
|
